Skip to main content

Table 3 Resistance to individual antimicrobials in 219 MRSA isolates from pigs

From: Prevalence, molecular epidemiology, and antimicrobial resistance of methicillin-resistant Staphylococcus aureus from swine in southern Italy

Antimicrobial target Antimicrobial class Antimicrobiala No. of non-susceptible (R + I) isolates (%)b
Peptidoglycan synthesis β-lactams PEN 219 (100)
OXA 219 (100)
AMS 145 (66.2)
Carbapenems IMP 22 (10.0)
Glycopeptides VAN 0 (0)
DNA synthesis Fluoroquinolones ENR 143 (65.3)
MAR 105 (47.9)
Protein synthesis Aminoglycosides GEN 43 (19.6)
KAN 47 (21.5)
Macrolides ERY 101 (46.1)
Lincosamides CLI 204 (93.1)
Tetracyclines TET 219 (100)
Fucidanes FUS 0 (0)
Phenicols CHL 16 (7.3)
Ansamycins RIF 1 (0.5)
Others Nitrofuranes NIT 10 (4.6)
Folate pathways inhibitors SXT 150 (68.4)
  1. aAcronyms: PEN, penicillin; OXA, oxacillin; AMS, ampicillin/sulbactam; IMP, imipenem; VAN; vancomicin; ENR, enrofloxacin; MAR, marbofloxacin; GEN, gentamycin; KAN, kanamycin; ERY, erythromycin; CLI, clindamycin; TET, tetracycline; FUS, fusidic acid; CHL, chloramphenicol; RIF, rifampicin; NIT, nitrofurantoin; SXT, trimethoprim-sulfamethoxazole
  2. bIsolates showing resistance (R) and intermediate susceptibility (I) were classified as non-susceptible